Skip to Content

4833M 15/500 (Actoplus Met 500 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill with imprint 4833M 15/500 is White, Elliptical / Oval and has been identified as Actoplus Met 500 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 500 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4833M 15/500

Actoplus met 500 mg / 15 mg 4833M 15/500
Actoplus met 500 mg / 15 mg 4833M 15/500 Front
Actoplus met 500 mg / 15 mg 4833M 15/500 Back
Actoplus met 500 mg / 15 mg 4833M 15/500

Actoplus Met

Generic Name:
metformin/pioglitazone
Imprint:
4833M 15/500
Strength:
500 mg / 15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0155

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide